feed,title,long_url,short_url
Benzinga,Pfizer Starts Pivotal Phase 3 Study of mRNA-Based Influenza Vaccine,https://benzinga.com/general/biotech/22/09/28864259/pfizer-starts-pivotal-phase-3-study-of-mrna-based-influenza-vaccine,https://bit.ly/3qzXinN
